Recent ELVN Stock Price | ELVN Stock Predictions | |
$22.92 | +49.78% |
$34.33 |
Recent ELVN Analyst Ratings Breakdown, Making ELVN Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 4 | 2 | 2 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the ELVN stock predictions from the analysts covering Enliven Therapeutics Inc, we have collected all of the individual ELVN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering ELVN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ELVN stock predictions may vary widely, another useful metric to consider is the median ELVN stock prediction, which represents the price at which half of the analysts
made ELVN stock predictions that were higher and half made ELVN stock predictions that were lower. This makes for a different take on the ELVN stock predictions out there, as compared to average or mean.
And that median across all the individual ELVN stock predictions was: $34.0 as of 2024-05-07.
The very highest of the ELVN stock predictions for one year price target was $37.0, while the very lowest of the ELVN stock predictions in the analyst group was
$32.0 (with a standard deviation of $2.516). Get the latest Zacks research report on ELVN — FREE
Find out: ELVN next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
CRNX Stock Predictions
RFIL Stock Predictions
NTCT Stock Predictions
LBRT Stock Predictions
CBSH Stock Predictions
PFLT Stock Predictions
JHX Stock Predictions
FENC Stock Predictions
CSIQ Stock Predictions
|
|
Strong Buy (4.00 out of 4) 93rd percentile
(ranked higher than approx. 93% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |